Tianjin Tianyao Pharmaceuticals Denies Acquisition By Pfizer
This article was originally published in PharmAsia News
Executive Summary
Tianjin Tianyao Pharmaceuticals, a dominant steroid manufacturer in China, has denied reports that it is in discussion with Pfizer for acquisition (PharmAsia News Jun. 23, 2008). According to company insiders, Tianyao and Pfizer have been collaborating for several years, and Tianyao is a raw material supplier for the pharmaceutical giant which monopolizes the steroid hormone market in China. To date, both parties' partnership has not changed, with Tianyao still a Pfizer's vendor. (Click here for more - Chinese Language)